ABSTRACT
Background/Aims: Stratification for gastric cancer risk typically involves histologic grading of gastric biopsies. This study aimed to compare endoscopic assessment of gastric atrophy and histologic gastric mapping for gastric cancer risk stratification in a region with relatively high risk of gastric cancer.Methods: Endoscopic and histologic gastric cancer risk stratification were compared in Vietnamese patients with functional dyspepsia. Endoscopic gastric atrophy was graded according to the Kimura-Takemoto classification. High-risk histologic lesions were defined as gastric dysplasia, Operative Link on Gastritis Assessment (OLGA) gastritis stage III/IV, intestinal metaplasia in both the antrum and the corpus or incomplete intestinal subtype at any site. Two experienced pathologists, blinded to endoscopic information, jointly examined all specimens and reached a consensus. The presence of high-risk histologic lesions was compared among patients with different endoscopic grades of gastric atrophy.Results: There were 280 subjects (mean age, 46.1 ± 10 years, and male, 50%). The numbers of patients with moderate/severe grade of endoscopic gastric atrophy and high-risk histologic lesions were 126 (45.0%) and 46 (16.4%), respectively. The sensitivity, specificity, positive and negative likelihood ratios of moderate/severe endoscopic atrophic grade for detecting high-risk histologic lesions were 93% (95% CI 86%-100%), 65% (95% CI 58%-71%), 2.64 (95% CI 2.18 - 3.18) and 0.10 (95% CI 0.03 - 0.30), respectively.Conclusions: Gastric cancer risk assessment using endoscopic or histologic methods provided similar results such that the absence or a mild grade of endoscopic gastric atrophy would preclude the need for histologic mapping.
Subject(s)
Gastric Mucosa/pathology , Gastritis, Atrophic/pathology , Helicobacter Infections/complications , Stomach Neoplasms/diagnosis , Adult , Female , Gastritis, Atrophic/classification , Gastritis, Atrophic/complications , Gastroscopy , Helicobacter Infections/pathology , Humans , Male , Metaplasia , Middle Aged , Retrospective Studies , Risk Assessment , Risk Factors , VietnamABSTRACT
Chronic gastritis is a long-lasting disease that can lead to a loss of appropriate gastric glands. Gastritis, as term, apply to an inflammation of the stomach, histologically proven, sometimes with structural mucosal changes. Worldwide Helicobacter pylori's infection play a pivotal role as the main etiological effector of chronic active gastritis. H. p. is a bacterium with a selective tropism for the gastric mucosa, able to survive in a hostile environment for colonization of organisms other than itself, able to develop strategies for survival and for avoidance of the defence mechanisms, causing inflammatory changes, that vary from asymptomatic mild gastritis to more severe injury such as peptic ulcer as well as premalignant lesions and malignant tumours. The pattern and distribution of gastritis strongly correlate with these sequelae and chronic atrophic gastritis with intestinal metaplasia is now assessed as a precancerous lesion with definite risk of evolution towards intraepithelial lesions of both low and high grade, as expected in the model of the Correa's cascade. In fact, the leading complication of chronic gastritis remains its close correlation with gastric cancer being biologically linked to H. pylori infection, nowadays known as a class I carcinogen. Gastric carcinogenesis is due to environmental factors, as well as to bacterial strain, host responses and gastric mucosal microbiome dysbiosis. Since, individual patients show different gastric cancer risk, it is mandatory to identify patients at risk of developing gastric cancer to offer a targeted search for lesions with a more rapid development of neoplasm liable, in an early phase, to a less destructive treatment. OLGA staging system is the most reliable and powerful system that allow the recognition of patient with a higher risk of developing gastric cancer.
Subject(s)
Gastritis, Atrophic/pathology , Precancerous Conditions/pathology , Severity of Illness Index , Biopsy , Disease Progression , Gastric Mucosa/microbiology , Gastric Mucosa/pathology , Gastritis, Atrophic/classification , Helicobacter Infections/pathology , Helicobacter pylori , Humans , Metaplasia , Stomach Neoplasms/etiologyABSTRACT
Gastric cancer (GC) is one of the most widespread types of cancer worldwide. Helicobacter pylori infection has been clearly correlated with gastric carcinogenesis. At present and in the near future, the most important challenge is and will be the significant reduction of mortality due to GC. That goal can be achieved through the identification of higher-risk patients, such as those with atrophic gastritis, intestinal metaplasia and dysplasia. In this review we intend to discuss the importance of diagnosing H. pylori infection and chronic atrophic gastritis in preventing gastric cancer, using a new non-invasive test called GastroPanel. This test is a classification algorithm including four biochemical parameters pepsinogen I and II (PGI and PGII), gastrin-17 (G17), and anti-Helicobacter pylori antibodies (Ig G anti-Hp) measured in fasting sera, which allows to classify patients as having atrophic or non-atrophic gastritis and to find whether gastritis is associated or not with H. pylori infection. GastroPanel is not a "cancer test", but it can and should be used in the screening and diagnosis of subjects with a high cancer risk; still, a careful diagnostic made by superior digestive endoscopy is compulsory to find possible precancerous or cancerous lesions at an early and curable stage.
Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Gastritis, Atrophic/complications , Gastritis, Atrophic/diagnosis , Helicobacter Infections/complications , Helicobacter Infections/diagnosis , Helicobacter pylori , Stomach Neoplasms/microbiology , Biomarkers/blood , Gastritis, Atrophic/classification , Gastritis, Atrophic/microbiology , Gastroscopy , Helicobacter Infections/classification , Humans , Risk Assessment/methods , Stomach Neoplasms/diagnosisABSTRACT
GOALS: To propose a new probe-based confocal laser endomicroscopy (pCLE) classification of gastric pit patterns and vessel architecture, and to assess the accuracy and interobserver agreement. BACKGROUND: pCLE is a newly developed endoscopic device that allows the application of laser microscopy with any conventional endoscope and mosaic imaging. STUDY: A total of 291 pCLE videos from 32 patients were recruited in phase I to establish the new pCLE image classification in the stomach. Eligible patients were then prospectively investigated by pCLE using the newly established classification system. All patients were examined first with high-definition endoscopy followed by pCLE at 7 standardized locations and endoscopic-suspected lesions. Targeted biopsies were performed with precise matching of pCLE recordings. RESULTS: The sensitivity and specificity of type 2b pit pattern for predicting atrophic gastritis were 88.51% and 99.19%, respectively. The sensitivity and specificity of type 2c pit pattern for predicting intestinal metaplasia were 92.34% and 99.34%, respectively. The overall sensitivity and specificity of type 3 pit pattern or vessel architecture for predicting neoplasia were 89.89% and 99.44%, respectively. The interobserver agreement was "substantial" (kappa=0.70) for the differentiation of neoplasia versus non-neoplasia. CONCLUSIONS: The new pCLE classification system in the stomach correlates well with specific pathologic conditions and is reproducible by multiple investigators. Multicenter researches are warranted to further validate its value in clinical practice.
Subject(s)
Gastric Mucosa/pathology , Gastritis, Atrophic/diagnosis , Microscopy, Confocal/methods , Stomach Diseases/diagnosis , Adult , Aged , Aged, 80 and over , Biopsy , Female , Gastritis, Atrophic/classification , Gastritis, Atrophic/pathology , Humans , Male , Middle Aged , Observer Variation , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity , Stomach Diseases/classification , Stomach Diseases/pathology , Young AdultABSTRACT
BACKGROUND: The severity of endoscopic gastric atrophy (EGA), high-stage Operative Link on Gastritis Assessment (OLGA) gastritis (i.e., stage III or IV), and extensive intestinal metaplasia (IM) with incomplete subtype have been separately reported as high-risk factors of gastric cancer (GC). The aim of this study was to evaluate the associations between these endoscopic and pathologic characteristics. MATERIALS AND METHODS: A cross-sectional study was conducted on 280 patients with functional dyspepsia at the University Medical Center at Ho Chi Minh City, Vietnam. Biopsies were taken according to the updated Sydney System. EGA was assessed according to the Kimura-Takemoto classification, and gastritis stage was assessed according to the OLGA system. RESULTS: All of patients with high-stage OLGA gastritis (i.e., stage III or IV) clustered in the subgroup of patients with moderate-to-severe EGA: 13/126 (10.3%) in patients with moderate-to-severe EGA versus 0/154 (0%) in patients with none-to-mild EGA (p < .001). Moderate-to-severe EGA was also significantly associated with extensive IM (p < .001, OR = 28.1 (CI 95% 6.4-173.3)) and incomplete IM subtype (p < .001, OR = 36.7 (CI 95% 5.1-742.1). Extensive IM was also associated with incomplete IM subtype (p = .01). CONCLUSIONS: High-stage OLGA gastritis, extensive IM with incomplete subtype clustered in patients with moderate-to-severe EGA. Assessing the severity of EGA could potentially help to identify patients who should be taken systemic biopsy for evaluating GC risk.
Subject(s)
Gastritis, Atrophic/pathology , Helicobacter Infections/complications , Intestines/pathology , Metaplasia/pathology , Adult , Aged , Cross-Sectional Studies , Female , Gastritis, Atrophic/classification , Gastritis, Atrophic/complications , Gastroscopy , Helicobacter Infections/microbiology , Helicobacter Infections/pathology , Helicobacter pylori/pathogenicity , Humans , Male , Metaplasia/complications , Middle Aged , Precancerous Conditions/complications , Precancerous Conditions/pathology , Risk Factors , Stomach Neoplasms/complications , Stomach Neoplasms/etiology , Stomach Neoplasms/pathology , Young AdultABSTRACT
BACKGROUND: It is not clear which screening examinations are best suited for gastric cancer prevention, especially in patients with atrophic gastritis and intestinal metaplasia. Therefore, we investigated the gastric cancer screening methods and intervals that are performed in clinical practice in an area with a high prevalence of gastric cancer. METHODS: Eighty-seven physicians voted by keypad and discussed the consistency of endoscopic diagnosis of atrophic gastritis and intestinal metaplasia at the Annual Symposium of the Korean College of Helicobacter and Upper Gastrointestinal Research. Additionally, 100 core members of this academic society were asked via e-mail to complete the questionnaires related to screening strategies for gastric cancer. RESULTS: The most common recommendation for the subjects with intestinal metaplasia was an annual endoscopic follow-up (95.5% vs. 80.4% in the expert and non-expert groups, respectively; P = 0.118). Annual endoscopic follow-up was also the most predominant recommendation for atrophic gastritis (95.5% vs. 76.5%; P = 0.092), regardless of the physicians' endoscopic experience, position, and degree of the hospital. However, the correct answer rate for the diagnosis of normal endoscopic findings was only 16.7 and 14.1% in the expert and non-expert groups, respectively (P = 0.883). CONCLUSIONS: The most common practical screening strategy for patients with atrophic gastritis and intestinal metaplasia in Korea was annual endoscopic examination. However, a new program estimating individualized gastric cancer risk might be needed because of the low inter-observer agreement in the endoscopic diagnosis of atrophic gastritis and intestinal metaplasia.
Subject(s)
Gastritis, Atrophic/ethnology , Intestinal Diseases/ethnology , Population Surveillance/methods , Stomach Neoplasms/ethnology , Stomach Neoplasms/prevention & control , Aged , Endoscopy, Gastrointestinal/methods , Endoscopy, Gastrointestinal/statistics & numerical data , Female , Follow-Up Studies , Gastritis, Atrophic/classification , Gastritis, Atrophic/pathology , Health Care Surveys/methods , Humans , Intestinal Diseases/pathology , Male , Mass Screening/methods , Mass Screening/statistics & numerical data , Medicine/statistics & numerical data , Metaplasia , Middle Aged , Observer Variation , Prevalence , Republic of Korea/epidemiology , Risk Factors , Stomach Neoplasms/pathologyABSTRACT
INTRODUCTION: Due to the poor agreement between endoscopy and histology, the gastric biopsy continues being the gold standard for the diagnosis of atrophic chronic gastritis. The Virtual chromoendoscopy system allows better observation of the gastric mucosa. OBJECTIVE: Evaluate the agreement between the Kimura-Takemoto ´s endoscopic system classification and the histological system of OLGA (Operative for Link Assessment Gastritis), as well as to evaluate the application of the virtual chromoendoscopy. METHODOLOGY: A prospective and longitudinal study of cohorts, 138 patients was include, using endoscopic system of atrophy by Kimura and Takemoto (K-T), with conventional optical and with the use of seventh filter of virtual chromoendoscopy ,then comparing with the histological findings of the OLGA pathology system, also were determinated injuries associated with respect to stage OLGA. RESULTS: The kappa index of agreement between conventional endoscopy and the system OLGA was 0.859 and with the system of virtual chromoendoscopy was 0.822, the preneoplasic and neoplastic gastric lesions were associate to stages III and IV of atrophy. CONCLUSIONS: The endoscopic and histological correlation with both systems isvery good, with or without the use of virtual chromoendoscopy. KEYWORDS: chronic atrophic gastritis, virtual chromoendoscopy, olga system, , kimuratakemoto system.
Subject(s)
Gastritis, Atrophic/pathology , Gastroscopy , Image Enhancement/methods , Adult , Aged , Biopsy , Chronic Disease , Color , Female , Filtration/instrumentation , Follow-Up Studies , Gastric Mucosa/pathology , Gastritis, Atrophic/classification , Gastritis, Atrophic/diagnosis , Humans , Male , Middle Aged , Prospective Studies , Severity of Illness Index , User-Computer Interface , Video Recording , Young AdultSubject(s)
Autoimmune Diseases/pathology , Gastric Mucosa/pathology , Gastritis, Atrophic/pathology , Polyps/pathology , Precancerous Conditions/pathology , Stomach Neoplasms/pathology , Autoimmune Diseases/classification , Biopsy , Gastritis, Atrophic/classification , Gastroscopy , Humans , Hyperplasia , Polyps/classification , Precancerous Conditions/classification , Stomach Neoplasms/classification , Terminology as TopicABSTRACT
BACKGROUND AND AIMS: The aims of the present study were to evaluate the role of moderate-to-severe endoscopic gastric atrophy (EGA) on predicting Operative Link on Gastritis Assessment (OLGA) gastritis stage, and to assess the association of high-stage OLGA gastritis with gastric neoplasia in patients with non-ulcer dyspepsia. METHODS: A cross-sectional study was carried out on 280 dyspeptic outpatients. EGA was assessed according to the Kimura-Takemoto classification. Gastritis stage was established according to the OLGA staging system and gastric neoplasia was assessed according to the Vienna classification. The pathologists who read the specimens were kept blind to the endoscopic results. RESULTS: The mean age of patients was 46.1 years (range 20-78 years) with a male-to-female ratio of 1:1. High-stage gastritis (e.g. stage III or IV) was confirmed in 13 (4.6%) patients. All of these patients were more than 40 years-of-age (P = 0.01), had Helicobacter pylori infection (P = 0.0006) and moderate-to-severe EGA (P < 0.001). Low-grade dysplasia was found in seven patients: 4/13 (30.7%) with high-stage gastritis versus 3/267 (1.1%) with low-stage gastritis (P < 0.001). Six of these patients had moderate-to-severe EGA (P = 0.048). The sensitivity, specificity, positive predictive value and negative predictive value of this endoscopic finding in high-stage gastritis diagnosis were 100%, 57.7%, 10.3% and 100%, respectively. CONCLUSIONS: OLGA high-stage gastritis was associated with gastric dysplasia and was mostly diagnosed in patients with moderate-to-severe EGA. The absence of this endoscopic finding could effectively rule out the possibility of having high-stage gastritis.
Subject(s)
Gastritis, Atrophic/diagnosis , Gastroscopy , Health Status Indicators , Stomach Neoplasms/etiology , Stomach/pathology , Adult , Aged , Cross-Sectional Studies , Female , Gastritis, Atrophic/classification , Gastritis, Atrophic/complications , Gastritis, Atrophic/pathology , Humans , Male , Middle Aged , Predictive Value of Tests , Prognosis , Prospective Studies , Risk Assessment , Risk Factors , Sensitivity and Specificity , Severity of Illness Index , Stomach Neoplasms/pathology , Terminology as Topic , Vietnam , Young AdultABSTRACT
BACKGROUND: The OLGA (operative link on gastritis assessment) staging system is based on severity of atrophic gastritis (AG). AG remains a difficult histopathologic diagnosis with low interobserver agreement, whereas intestinal metaplasia (IM) is associated with high interobserver agreement. OBJECTIVE: The aim of this study was to evaluate whether a staging system based on IM is preferable to estimate gastric cancer risk. DESIGN AND SETTING: Prospective multicenter study. PATIENTS: A total of 125 patients previously diagnosed with gastric IM or dysplasia. INTERVENTIONS: Surveillance endoscopy with extensive biopsy sampling. MAIN OUTCOME MEASUREMENTS: Three pathologists graded biopsy specimens according to the Sydney classification. Interobserver agreement was analyzed by kappa statistics. In the OLGA, AG was replaced by IM, creating the OLGIM. RESULTS: Interobserver agreement was fair for dysplasia (kappa = 0.4), substantial for AG (kappa = 0.6), almost perfect for IM (kappa = 0.9), and improved for all stages of OLGIM compared with OLGA. Overall, 84 (67%) and 79 (63%) patients were classified as stage I-IV according to OLGA and OLGIM, respectively. Of the dysplasia patients, 5 (71%) and 6 (86%) clustered in stage III-IV of OLGA and OLGIM, respectively. LIMITATION: Prospective studies should confirm the correlation between gastric cancer risk and OLGIM stages. CONCLUSION: Replacement of AG by IM in the staging of gastritis considerably increases interobserver agreement. The correlation with the severity of gastritis remains at least as strong. Therefore, the OLGIM may be preferred over the OLGA for the prediction of gastric cancer risk in patients with premalignant lesions.
Subject(s)
Endoscopy, Gastrointestinal/methods , Gastric Mucosa/pathology , Gastritis, Atrophic/pathology , Precancerous Conditions/pathology , Risk Assessment/methods , Stomach Neoplasms/pathology , Aged , Biopsy , Diagnosis, Differential , Disease Progression , Female , Follow-Up Studies , Gastritis, Atrophic/classification , Humans , Male , Metaplasia/pathology , Middle Aged , Prospective Studies , ROC Curve , Reproducibility of Results , Severity of Illness IndexABSTRACT
INTRODUCTION: H. pylori gastritis and autoimmune gastritis are the two main types of chronic atrophic gastritis. Parietal cell antibody (PCA) and intrinsic factor antibody (IFA) are characteristic of autoimmune gastritis, of which IFA is more specific. Patients who are IFA negative are considered under the category of chronic atrophic gastritis. AIM: To differentiate IFA positive from IFA negative chronic atrophic gastritis. METHODS: Fifty consecutive patients of biopsy proven chronic atrophic gastritis were included in this study. All patients underwent haematological and biochemical tests including serum LDH, vitamin B12 and fasting serum gastrin levels. PCA and IFA antibodies were tested in all patients. Multiple gastric biopsies from body and antrum of the stomach were taken and evaluated for presence of intestinal metaplasia, endocrine cell hyperplasia, carcinoid and H. pylori infection. Patients were grouped as group A (IFA positive) and group B (IFA negative). The mean laboratory values and histological parameters were compared between the two groups using appropriate statistical methods. RESULTS: Eighteen patients were in group A (mean age 55.5 +/- 13 years, male: female = 16:2) and thirty-two in group B (mean age 49.7 +/- 13 years, male: female = 25:7). There was no statistically significant difference between median values of haemoglobin, MCV, LDH, Vitamin B12 and serum gastrin in both the groups. None of the histological parameters showed any significant difference. CONCLUSION: There was no statistically significant difference in haematological, biochemical and histological parameters in IFA positive and negative gastritis. These may be the spectrum of the same disease, where H. pylori may be responsible for initiating the process.
Subject(s)
Anemia, Pernicious , Gastritis, Atrophic , Intrinsic Factor/immunology , Adult , Aged , Anemia, Pernicious/classification , Anemia, Pernicious/immunology , Anemia, Pernicious/pathology , Autoantibodies/immunology , Biopsy , Diagnosis, Differential , Endoscopy, Digestive System , Female , Gastritis, Atrophic/classification , Gastritis, Atrophic/immunology , Gastritis, Atrophic/pathology , Helicobacter Infections/immunology , Helicobacter Infections/pathology , Helicobacter pylori , Humans , Male , Middle Aged , Parietal Cells, Gastric/immunologyABSTRACT
BACKGROUND AND AIM: The endoscopic grading of the gastroesophageal flap valve (GEFV) has been suggested to be a good predictor of reflux status. Atrophic gastritis is inversely associated with reflux esophagitis. The aim of the present study was to investigate the association between GEFV, atrophic gastritis and gastroesophageal reflux. METHODS: A total of 608 patients (252 men and 356 women; mean age 51.1 years) who underwent endoscopy, esophageal manometry and ambulatory 24-h pH monitoring were included. GEFV was graded I through IV using Hill's classification: the GEFV was largely classified into two groups: the normal GEFV group (grades I and II) and the abnormal GEFV group (grades III and IV). Atrophic gastritis was classified into two groups by endoscopic atrophic border: closed-type (C-type) and open-type (O-type). Findings of endoscopy, esophageal manometry and ambulatory pH monitoring were compared among the groups. RESULTS: The incidence of reflux esophagitis and gastroesophageal reflux disease was associated with an abnormal GEFV grade and was inversely associated with open-type atrophic gastritis. The patients with a coexisting abnormal GEFV and closed-type atrophic gastritis showed a significantly higher incidence of reflux esophagitis and gastroesophageal reflux disease than the patients with a coexisting normal GEFV and open-type atrophic gastritis (OR, 20.6 [95% CI, 6.2-68.4], 11.4 [95% CI, 6.3-20.7], respectively). CONCLUSIONS: Endoscopic grading of GEFV and atrophic gastritis is simple and provides useful information on the status of gastroesophageal reflux.
Subject(s)
Endoscopy, Gastrointestinal , Esophagitis, Peptic/etiology , Esophagogastric Junction/pathology , Gastritis, Atrophic/complications , Gastritis, Atrophic/pathology , Gastroesophageal Reflux/complications , Gastroesophageal Reflux/epidemiology , Esophageal pH Monitoring , Esophagitis, Peptic/epidemiology , Esophagus/pathology , Female , Gastritis, Atrophic/classification , Gastroesophageal Reflux/diagnosis , Humans , Incidence , Male , Manometry , Metaplasia , Middle Aged , Predictive Value of Tests , Retrospective StudiesABSTRACT
PURPOSE OF REVIEW: The majority of problems in interpreting gastritis remain Helicobacter related, but their nature has changed. The present review covers gastritis historically through cancer risk staging systems. RECENT FINDINGS: Key points to remember are: Helicobacter is associated with several forms of gastritis; in the present review, I am focusing on the two ends of the disease, 'Helicobacter pylori infection', that starts with antral predominant gastritis but can continue to oxyntic predominant disease with atrophy; the role Helicobacter pylori plays in autoimmune gastritis with pernicious anemia remains unresolved; gastritis staging systems for cancer risk, namely Baylor and Operative Link on Gastritis Assessment, are currently available. SUMMARY: As most gastric carcinomas arise on a background of atrophic gastritis, and the risk increases with the extent of atrophy, an index of atrophy location and extent could be useful in predicting patients at greatest risk for carcinoma. It is now possible to stage patients for cancer risk. Nonetheless, in a field such as gastritis in which many issues remain unresolved, a classification or staging system that is more descriptive will likely prove more useful.
Subject(s)
Gastric Mucosa/pathology , Gastritis, Atrophic , Atrophy , Disease Progression , Gastric Mucosa/microbiology , Gastritis, Atrophic/classification , Gastritis, Atrophic/complications , Gastritis, Atrophic/pathology , Helicobacter Infections/complications , Helicobacter Infections/epidemiology , Helicobacter Infections/pathology , Helicobacter pylori/isolation & purification , Humans , Incidence , Risk Factors , Stomach Neoplasms/epidemiology , Stomach Neoplasms/etiology , Stomach Neoplasms/pathologyABSTRACT
BACKGROUND: Reflux esophagitis is inversely associated with the presence of atrophic gastritis, and endoscopic grading of atrophic gastritis correlates with histological evaluation. The aim of this study was to investigate the association of the endoscopic grade of atrophic gastritis with gastroesophageal and gastropharyngeal reflux. METHODS: A total of 627 patients, who underwent endoscopy and ambulatory 24-hour dual-probe pH monitoring, were included in this study. The grade of atrophic gastritis was endoscopically classified into 2 types with the atrophic pattern system: the closed-type (C-type) and the open-type (O-type). We compared the findings from endoscopy and ambulatory pH monitoring for these 2 types. RESULTS: The O-type was significantly associated with a lower prevalence of reflux esophagitis (p = 0.001). All variables showing gastroesophageal reflux in the distal probe were significantly lower in the O-type than in the C-type (p < 0.05). Similarly for the proximal probe, all variables, except the supine time of pH < 4, were significantly lower in the O-type than in the C-type (p < 0.05). The frequency of gastroesophageal reflux disease and gastropharyngeal reflux disease was in significantly lower in the O-type than in the C-type (p < 0.001, p = 0.012, respectively). CONCLUSIONS: Endoscopic grading of atrophic gastritis is easy and is inversely associated with gastroesophageal and gastropharyngeal reflux.
Subject(s)
Endoscopy, Gastrointestinal , Gastritis, Atrophic/physiopathology , Gastroesophageal Reflux/physiopathology , Pharynx/pathology , Esophageal pH Monitoring , Female , Gastritis, Atrophic/classification , Gastroesophageal Reflux/epidemiology , Health Status Indicators , Humans , Korea/epidemiology , Male , Middle Aged , Prevalence , Retrospective Studies , Risk FactorsABSTRACT
BACKGROUND: Reflux esophagitis is inversely associated with the presence of atrophic gastritis, and endoscopic grading of atrophic gastritis correlates with histological evaluation. The aim of this study was to investigate the association of the endoscopic grade of atrophic gastritis with gastroesophageal and gastropharyngeal reflux. METHDOS: A total of 627 patients, who underwent endoscopy and ambulatory 24-hour dual-probe pH monitoring, were included in this study. The grade of atrophic gastritis was endoscopically classified into 2 types with the atrophic pattern system: the closed-type (C-type) and the open-type (O-type). We compared the findings from endoscopy and ambulatory pH monitoring for these 2 types. RESULTS: The O-type was significantly associated with a lower prevalence of reflux esophagitis (p=0.001). All variables showing gastroesophageal reflux in the distal probe were significantly lower in the O-type than in the C-type (p<0.05). Similarly for the proximal probe, all variables, except the supine time of pH<4, were significantly lower in the O-type than in the C-type (p<0.05). The frequency of gastroesophageal reflux disease and gastropharyngeal reflux disease was in significantly lower in the O-type than in the C-type (p<0.001, p=0.012, respectively). CONCLUSIONS: Endoscopic grading of atrophic gastritis is easy and is inversely associated with gastroesophageal and gastropharyngeal reflux.
Subject(s)
Female , Humans , Male , Middle Aged , Endoscopy, Gastrointestinal , Esophageal pH Monitoring , Gastritis, Atrophic/classification , Gastroesophageal Reflux/epidemiology , Health Status Indicators , Korea/epidemiology , Pharynx/pathology , Prevalence , Retrospective Studies , Risk FactorsABSTRACT
BACKGROUND AND AIMS: Infection with Helicobacter pylori (Hp) has been linked to atrophic gastritis, an inflammatory precursor of non-cardia gastric carcinoma. Mutations in the p53 gene are one of the most frequent genetic alterations in gastric carcinoma. In a subgroup of atrophic gastritis, antiparietal cell antibody (APCA) has been detected. This study was aimed to clarify the role of APCA in the progression of atrophic gastritis and gastric carcinogenesis, and to determine the relationship of the severity of atrophic gastritis to gastric carcinoma and to p53 mutations. METHODS: In 494 control subjects and 284 gastric carcinoma patients, serum APCA was evaluated and all subjects and patients were classified into four groups using serologic markers (anti-Hp IgG antibody and pepsinogen (PG) test: positive; PG I < 70 microg/L and PG I/II ratio < 3.0) as follows: A, HP- PG-; B, HP+ PG-; C, HP+ PG+ and D, HP- PG+. p53 mutations were analyzed in 174 of 284 patients. RESULTS: Antiparietal cell antibody seropositivity increased from group B to D, however, no difference in its positivity was found between controls and patients. The incidence of gastric carcinoma increased from A to D, especially the intestinal subtype. The frequency of p53 gene mutations was higher in PG+ than in PG- gastric carcinoma. CONCLUSIONS: Antiparietal cell antibody seropositivity is involved in the progression of a subgroup of atrophic gastritis, but not associated with gastric carcinogenesis. Severe atrophic gastritis is associated with susceptibility to gastric carcinoma, especially the intestinal subtype, and p53 mutations.
Subject(s)
Antibodies, Anti-Idiotypic/analysis , Gastritis, Atrophic/genetics , Gastritis, Atrophic/immunology , Tumor Suppressor Protein p53/genetics , Adult , Aged , Aged, 80 and over , Chi-Square Distribution , Disease Progression , Female , Gastritis, Atrophic/classification , Gastritis, Atrophic/microbiology , Helicobacter Infections/complications , Helicobacter Infections/immunology , Helicobacter pylori/immunology , Humans , Logistic Models , Male , Middle Aged , Mutation , Severity of Illness Index , Statistics, Nonparametric , Stomach Neoplasms/genetics , Stomach Neoplasms/immunology , Stomach Neoplasms/microbiologySubject(s)
Gastritis, Atrophic/etiology , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Autoimmunity , Crohn Disease/complications , Duodenogastric Reflux/complications , Gastric Stump , Gastritis, Atrophic/classification , Gastritis, Atrophic/epidemiology , Helicobacter Infections , Helicobacter pylori , Humans , Smoking/adverse effectsABSTRACT
Classifications of chronic gastritis and neoplastic gastric diseases, developed in recent years (1996 Houston update of 1990 Sidney classification system, 2002 New Orlean classification of atrophic gastritis according to recommendations of International Group for Atrophy Studies; 1998 Padova classification of gastric displasia, and 1998 Vienna classification of gastrointestinal neoplasia) allow to statandardize international research and perform more objective diagnostics of pathological changes in the gastric mucosa. Studies carried out in recent years have established that morphological manifestations of chronic gastritis caused by Helicobacter pylori infection can be reduced after its eradication. Longterm treatment with proton pump inhibitors have been demonstrated not to cause atrophic changes in the gastric mucosa when undertaken after successful eradicational therapy. It has been established that corporal gastritis intensifies in patients treated with proton pump inhibitors. The studies show that measurement of serum levels of Helicobacter pylori antibodies, gastrine, pepsinogen I and II can be used in non-invasive serologic diagnostics of atrophic gastritis. Achievements in diagnostics and treatment of chronic gastritis create the necessary prerequisites for the development of gastric cancer preventing measures.
Subject(s)
Gastritis , Helicobacter Infections , Helicobacter pylori , Antibodies, Bacterial/analysis , Biopsy , Chronic Disease , Dyspepsia/diagnosis , Gastric Mucosa/pathology , Gastrins/blood , Gastritis/classification , Gastritis/diagnosis , Gastritis/etiology , Gastritis/pathology , Gastritis/therapy , Gastritis, Atrophic/classification , Gastritis, Atrophic/diagnosis , Gastritis, Atrophic/etiology , Gastritis, Atrophic/pathology , Gastrointestinal Neoplasms/classification , Gastrointestinal Neoplasms/pathology , Helicobacter Infections/complications , Helicobacter Infections/diagnosis , Helicobacter Infections/drug therapy , Helicobacter Infections/immunology , Helicobacter pylori/immunology , Humans , Pepsinogen A/blood , Pepsinogen C/blood , Proton Pump Inhibitors , Stomach/pathology , Stomach Neoplasms/classification , Stomach Neoplasms/pathology , Stomach Neoplasms/prevention & control , Time FactorsABSTRACT
El concepto de gastritis crónica siempre ha sido motivo de controversia. Con el propósito de eliminar confusiones diagnósticas se crea en Sydney (Australia) un sistema de clasificación y gradación (Sistema Sydney). El presente estudio se propuso determinar la utilidad y reproducibilidad de este sistema para la gradación y clasificación de las gastritis crónicas y determinar la correlación endoscópica con la misma. La investigación se realizó en 55 pacientes sometidos a endoscopia digestiva alta y que tuvieron diagnóstico endoscópico de gastritis crónica. El estudio fue de tipo descriptivo, prospectivo y longitudinal. Con base en el Sistema Sydney, se hizo una clasificación de signos endoscópicos y se empleó una guía visual, propuesta también por el Sistema, para su lectura histopatológica.Todos los pacientes incluidos en el estudio con el diagnóstico de gastritis crónica fueron corroborados en estudio histopatológico como tal. El hallazgo endoscópico predominante fue el eritema en parches o en estrías de la mucosa, y estuvo presente en 98,2/100 de los pacientes.No hubo correlación endoscópica-histopatológica en lo que respecta al diagnóstico por regiones anatómicas (antral-antrocorporal) o en su gradación (niveles de severida).Se encontraron relaciones importantes entre los signos endoscópicos de hiperplasia y nodularidad con la presencia de Helicobacter pylori, la existencia de metaplasia intestinal incompleta en la incisura angularis y la relación H. pylori-actividad (neutrófilos).Para unificar criterios de diagnóstico y lenguaje se recomienda el uso de la guía visual y se comprueba la utilidad y reproducibilidad del Sistema Sydney